VA

VR Adviser Portfolio holdings

AUM $1.33B
1-Year Est. Return 6.92%
This Quarter Est. Return
1 Year Est. Return
+6.92%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.33B
AUM Growth
+$159M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
40
New
Increased
Reduced
Closed

Top Buys

1
+$34.7M
2
+$32.2M
3
+$31.7M
4
CBIO
Crescent Biopharma
CBIO
+$21.9M
5
SVRA icon
Savara
SVRA
+$12.8M

Top Sells

1
+$37.5M
2
+$20.1M
3
+$18.7M
4
DNTH icon
Dianthus Therapeutics
DNTH
+$13.9M
5
SLDB icon
Solid Biosciences
SLDB
+$9.18M

Sector Composition

1 Healthcare 99.4%
2 Financials 0.6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
APGE icon
1
Apogee Therapeutics
APGE
$3.65B
$369M 27.64%
8,493,321
OCUL icon
2
Ocular Therapeutix
OCUL
$2.43B
$118M 8.88%
12,762,462
MTSR
3
Metsera Inc
MTSR
$5.57B
$107M 8%
3,750,662
ELVN icon
4
Enliven Therapeutics
ELVN
$1.21B
$80.8M 6.05%
4,026,331
KALV icon
5
KalVista Pharmaceuticals
KALV
$562M
$76.1M 5.7%
6,728,985
+25,000
ORIC icon
6
Oric Pharmaceuticals
ORIC
$1.16B
$67M 5.02%
6,596,885
+3,414,358
VRDN icon
7
Viridian Therapeutics
VRDN
$1.79B
$54.3M 4.07%
3,882,709
ORKA
8
Oruka Therapeutics
ORKA
$1.25B
$46.5M 3.48%
4,148,428
SYRE icon
9
Spyre Therapeutics
SYRE
$1.71B
$40.2M 3.01%
2,685,448
PHVS icon
10
Pharvaris
PHVS
$1.48B
$36M 2.7%
2,047,620
-1,065,100
COGT icon
11
Cogent Biosciences
COGT
$2.02B
$34.1M 2.56%
4,755,411
-929,000
JBIO
12
Jade Biosciences
JBIO
$461M
$32.2M 2.41%
+3,220,364
CTMX icon
13
CytomX Therapeutics
CTMX
$544M
$31.7M 2.38%
+13,969,882
CDTX icon
14
Cidara Therapeutics
CDTX
$2.48B
$31.1M 2.33%
639,088
-412,430
UPB
15
Upstream Bio Inc
UPB
$1.19B
$25.2M 1.89%
2,295,319
ERAS icon
16
Erasca
ERAS
$641M
$22.7M 1.7%
17,857,083
+1,640,867
CBIO
17
Crescent Biopharma
CBIO
$210M
$22.4M 1.68%
1,387,864
+1,357,864
DYN icon
18
Dyne Therapeutics
DYN
$2.32B
$20.7M 1.55%
2,173,913
SVRA icon
19
Savara
SVRA
$712M
$20.3M 1.52%
8,884,263
+5,626,624
DNTH icon
20
Dianthus Therapeutics
DNTH
$1.33B
$18.6M 1.4%
1,000,000
-744,373
ENGN icon
21
enGene Holdings
ENGN
$403M
$18.4M 1.38%
5,046,414
ATXS icon
22
Astria Therapeutics
ATXS
$689M
$13.2M 0.99%
2,457,348
CGEM icon
23
Cullinan Oncology
CGEM
$494M
$10.4M 0.78%
1,379,965
ABVX
24
Abivax
ABVX
$6.92B
$10.3M 0.77%
1,345,780
PCSC
25
Perceptive Capital Solutions
PCSC
$7.96M 0.6%
750,000
1
2